“The partnership between Hà Nội Oncology Hospital and Roche Vietnam over the last years has brought positive impacts to patients. The new cooperation will help strengthen the relationship between the two organisations with the strong focus on cancer patients and the community in the most tangible way," said the Hà Nội Oncology Hospital director Bùi Vinh Quang.
“Roche Vietnam proudly continues the partnership with Hà Nội Oncology Hospital as a part of our long-term commitment, setting patients at the core to improve the comprehensive competencies of cancer treatment in Việt Nam. By leveraging Roche's global strengths and innovative solutions, accompanied with the dedicated team of Hà Nội Oncology Hospital, we wish to contribute positive impacts to progress in healthcare as well as bring outcomes throughout the patient-journey from diagnostics to treatment. This effort is not only to improve the living quality of people with cancer but also reduce the mortality and burdens it caused as well," said Girish Mulye, General Director of Roche Pharma Vietnam.
According to the GLOBOCAN 2020, there are more than 350,000 cancer patients in Việt Nam, over 182,000 new cases and 122,000 deaths of cancer yearly. A large-scale study by the Economist Intelligence Unit (EIU) in June 2020 also showed that the mortality rate of cancer cases in Việt Nam was beyond 70 per cent, ranking in the highest group among Asian countries. Most cancer patients are diagnosed and treated at a late-stage, leading them to the verge of death. This has caused many challenges in treatment as well as burdens on the patients, the healthcare system and society, showing an urge to accelerate the improvement of diagnosis and cancer treatment quality. — VNS